t.wojcik
TL2 Moderator · Galway
Contributes reviews on supplier material. Based in Galway.
Joined 23 October 2024 · last posted 11d
79 posts, newest first. Showing up to 150.
-
Review: a draft on reconstitution arithmetic, with objections — one year on Replied, post #46 · Documentation › Doc review · 17 Jul 2026 · 0 likes Evidence synthesis requests: if you think a page should summarise the state of evidence on a question, and you think the information exists but is scattered, suggest…
-
Revisiting: The report format the maintainers ask for, and why each field is there Replied, post #101 · Sourcing › Vendor reports · 13 Jul 2026 · 3 likes Testing service selection: Janoshik gives purity with chromatogram. Medutest gives combined purity and identity. PeptideMeter gives verification records as well as…
-
A single out-of-range value on an otherwise normal panel Replied, post #69 · Clinical › Bloodwork · 6 Jul 2026 · 2 likes Picking up post #66: that is the part I would want checked first. Biological variation: the person-to-person variation in a biomarker for a healthy person is larger…
-
How much context is too much context in a first post? Replied, post #28 · Start Here › How to Ask · 6 Jul 2026 · 4 likes Questions you cannot explain: "I cannot say why I am asking this, but is this compound stable at room temperature?" is more productive than no question at all. People…
-
About the Shortages category Replied, post #5 · Access › Shortages · 2 Jul 2026 · 13 likes Dose hold versus tapering: if a temporary shortage forces a gap, holding your dose and resuming when supply returns is different from gradually tapering. The two are…
-
Journal club: what we got wrong in an earlier session Replied, post #39 · Evidence › Journal club · 29 Jun 2026 · 0 likes Coming back to post #37, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic and I…
-
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #80 · Compounds › Repair & healing peptides · 27 Jun 2026 · 10 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Coming back to: Time to steady state after a dose increase Replied, post #83 · Pharmacology › Pharmacokinetics · 22 Jun 2026 · 28 likes Worth separating two things that post #79 runs together. Hepatic metabolism: the degree to which each compound is hepatically metabolised versus renally cleared is…
-
Dizziness on standing and the electrolyte explanation — does this still hold? Replied, post #95 · Practice › Side effects · 18 Jun 2026 · 24 likes Gallbladder complications: rapid weight loss increases the risk of gallstone formation. The mechanism is not specific to this drug class. The risk is greatest in the…
-
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #59 · Safety › Contraindications · 2 Jun 2026 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Comparing prices across jurisdictions without misleading yourself Replied, post #15 · Access › Pricing · 29 May 2026 · 0 likes This follows post #12 rather than contradicting it. Biosimilars and future generics: as patents expire, biosimilar and generic versions might become available and…
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #33 · Compounds › Semaglutide · 20 May 2026 · 28 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #114 · Devices › Syringes & needles · 13 May 2026 · 11 likes I read post #112 twice before replying, because I had assumed the opposite. Aspirating before injection: for subcutaneous injection, aspirating (pulling back on the…
-
Coming back to: A structured critique template this community uses Replied, post #9 · Evidence › Study critique · 10 May 2026 · 0 likes post #8 answers the question as asked. The question underneath it is different. Generalisability: do the inclusion/exclusion criteria narrow the population so much that…
-
Revisiting: What pooling buys you and what it destroys Replied, post #16 · Evidence › Meta-analyses · 8 May 2026 · 3 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Fasting versus non-fasting and which tests care Replied, post #23 · Clinical › Bloodwork · 5 May 2026 · 0 likes TSH and free hormones: TSH is a reasonable screening test but does not tell you about actual free hormone levels. If TSH is abnormal, free thyroid hormones confirm…
-
Follow-up: The retatrutide phase 2 obesity paper, read closely Replied, post #12 · Compounds › Retatrutide · 4 May 2026 · 2 likes I read post #10 twice before replying, because I had assumed the opposite. Phase 2 sample sizes are not adequate for safety characterisation of a novel triple agonist.…
-
Revisiting: Journal club: SURMOUNT-1, read without the press release Replied, post #33 · Evidence › Journal club · 7 Apr 2026 · 0 likes Worth separating two things that post #29 runs together. SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0 mg. The 1.0 mg dose is not…
-
Trust level 3 requirements: a clarification — does this still hold? Replied, post #27 · Meta › Announcements · 7 Apr 2026 · 14 likes Scheduled maintenance: if the site is going offline for maintenance, advance notice will be posted here with the duration and scope.
-
Coming back to: Semaglutide in people without diabetes: what the evidence base looks like Replied, post #44 · Compounds › Semaglutide · 27 Mar 2026 · 32 likes The C-cell question: semaglutide triggered medullary thyroid carcinoma in rodent toxicology studies. A signal in rodents does not automatically appear in humans, but it…
-
[2026 update] Amylin and gastric emptying: overlapping mechanisms with incretins Replied, post #17 · Compounds › Cagrilintide & amylin analogues · 2 Mar 2026 · 13 likes For anyone arriving from searches on "amylin agonist": this subcategory discusses published clinical evidence and what it does and does not establish. It does not…
-
Coming back to: Reading a supplier's product description as a marketing document Replied, post #34 · Compounds › Other compounds · 23 Feb 2026 · 3 likes Why catalogue breadth is not evidence of anything: a supplier listing 500 compounds does not make the 450 untested ones likely to work. It makes them untested compounds…
-
[2026 update] Long-time reader, first-time poster Replied, post #44 · Lounge › Introductions · 23 Jan 2026 · 29 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Storing lyophilised material long term: what governs the shelf life Replied, post #32 · Practice › Storage & stability · 20 Jan 2026 · 10 likes Picking up post #29: that is the part I would want checked first. Dating prepared solutions: write the date reconstitution on the vial in permanent marker. If you later…
-
What "verified" means on our vendor pages, stated narrowly Replied, post #7 · Sourcing › Vendor reports · 24 Dec 2025 · 13 likes Picking up post #4: that is the part I would want checked first. Multiple services on one lot: agreement across two independent laboratories is stronger than a high…
-
Micro-titration: a disputed topic, argued properly Replied, post #13 · Practice › Dosing & titration · 18 Dec 2025 · 0 likes Picking up post #10: that is the part I would want checked first. Steady state means the plasma concentration is stable from dose to dose. That happens around 4 to 5…
-
Stepping down deliberately, and how to do it without losing progress Replied, post #25 · Practice › Dosing & titration · 9 Dec 2025 · 16 likes Splitting a weekly dose in two: the pharmacokinetic argument against is that you want the benefit of long half-life, which gives a slowly changing plasma level from a…
-
Common supplements people ask about, assessed one at a time — a second dataset Replied, post #17 · Practice › Interactions · 7 Dec 2025 · 27 likes On post #13 — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
-
DXA precision and the least significant change for lean mass Replied, post #36 · Outcomes › Body composition · 2 Dec 2025 · 12 likes post #35 answers the question as asked. The question underneath it is different. Changes during titration: measuring body composition during active titration is less…
-
Tracking that stops updating and then resumes — the long version Replied, post #36 · Sourcing › Logistics · 9 Nov 2025 · 1 like Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Coming back to: Why quantitation is the hard part, not detection Replied, post #91 · Analytics › Home & field testing · 9 Nov 2025 · 0 likes Coming back to post #89, because the follow-up matters more than the original answer. Precision of home tests: most consumer-accessible devices are not precise to the…
-
EMA product information as a primary source Replied, post #21 · Regional › European Union · 1 Nov 2025 · 3 likes Picking up post #18: that is the part I would want checked first. Cross-border purchase rules: buying a prescription in one EU country and bringing it home is complex.…
-
Appeal templates and why they are deliberately unemotional Replied, post #20 · Access › Insurance & coverage · 26 Oct 2025 · 0 likes Prior authorisation: pre-approval requirements and how to satisfy them. Most denials cite specific criteria. Understanding the criterion is the first step in satisfying…
-
What happens after your first post: likes, trust levels, and why none of it matters much… Replied, post #52 · Start Here › Welcome · 17 Oct 2025 · 10 likes Welcome. The orientation materials are pinned at the top of this category and they take about an hour. They answer most of the questions a new member has and they save…
-
Liver enzymes drifting down and what that usually means Replied, post #13 · Clinical › Bloodwork · 22 Sep 2025 · 3 likes Analytical imprecision: any measurement has an error margin. A small difference in consecutive tests is usually measurement noise, not a real change. Knowing the…
-
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #57 · Evidence › Study critique · 14 Sep 2025 · 21 likes Picking up post #54: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
Journal club: STEP-HFpEF and symptom endpoints Replied, post #4 · Evidence › Journal club · 31 Aug 2025 · 0 likes SOUL (N Engl J Med 2025): Oral semaglutide cardiovascular outcomes. Extends the cardiovascular evidence to the oral formulation. Note that oral bioavailability is lower…
-
Revisiting: Filter needles: when they help and what they cost you Replied, post #48 · Devices › Syringes & needles · 22 Aug 2025 · 4 likes Picking up post #45: that is the part I would want checked first. Insulin syringe graduations: U-100 syringes are marked in units where 100 units = 1 mL. Always confirm…
-
Which panel is worth repeating and which is worth ignoring Replied, post #77 · Clinical › Bloodwork · 5 Aug 2025 · 0 likes Picking up post #74: that is the part I would want checked first. Reference intervals: constructed to contain the central 95% of a reference population, which means one…
-
Travel coolers and how long they really hold Replied, post #19 · Devices › Cold chain · 1 Aug 2025 · 0 likes On post #15 — agreed on the reasoning, with one qualification. Shipment during summer or to hot climates: consider shipping to a cold-storage facility rather than to…
-
Checking someone else's arithmetic: a worked example thread Replied, post #72 · Practice › Reconstitution · 29 Jul 2025 · 17 likes I read post #70 twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want to say…
-
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #30 · Sourcing › Vendor reports · 25 Jul 2025 · 25 likes On post #26 — agreed on the reasoning, with one qualification. Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if the other mass is…
-
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #53 · Access › Insurance & coverage · 22 Jul 2025 · 14 likes Coverage for weight management versus diabetes: many formularies cover these compounds for type 2 diabetes but not for weight management. The indication matters and…
-
Reaching a dose and staying there for a year: a longitudinal note — does this still hold? Replied, post #11 · Practice › Dosing & titration · 12 Jul 2025 · 12 likes On post #7 — agreed on the reasoning, with one qualification. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly…
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #137 · Devices › Cold chain · 6 Jul 2025 · 2 likes On post #133 — agreed on the reasoning, with one qualification. Freeze-thaw: some peptides tolerate freezing; others do not. Check your compound's labelling. Generally,…
-
[2026 update] Constipation management, with a dietitian's contribution Replied, post #5 · Practice › Side effects · 16 Jun 2025 · 20 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #69 · Practice › Reconstitution · 13 Jun 2025 · 1 like Arithmetic step by step: a 5 mg vial with 2 mL of diluent gives (5 mg) / (2 mL) = 2.5 mg/mL. On a U-100 syringe at that concentration, 100 units = 1 mL = 2.5 mg, so…
-
A report I filed that turned out to be wrong, and the correction Replied, post #101 · Sourcing › Vendor reports · 13 Jun 2025 · 10 likes Structured report format: compound, lot, independent testing service, method as reported, result, and the certificate figure for the same lot. One lot is one lot. It…
-
Coming back to: Sample size calculations, read backwards from the published number Replied, post #39 · Evidence › Trials · 12 Jun 2025 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Forced degradation studies: designing one that is informative — does this still hold? Replied, post #12 · Analytics › Method validation · 9 Jun 2025 · 4 likes I read post #10 twice before replying, because I had assumed the opposite. Range: the concentration range over which the method has been validated. Going outside the…
-
Pre-registering a personal experiment, seriously Replied, post #15 · Research Methods › N-of-1 designs · 26 May 2025 · 17 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Why oral semaglutide needs an absorption enhancer at all Replied, post #6 · Compounds › Oral incretins · 14 May 2025 · 0 likes post #5 is right about the mechanism and I think understates the practical bit. Orforglipron is a small molecule, not a peptide. That changes almost everything: no…
-
Coming back to: Official shortage notices and what they authorise Replied, post #4 · Access › Shortages · 10 May 2025 · 6 likes This follows post #2 rather than contradicting it. Patient advocacy during shortages: some advocacy groups advocate for patients during shortages. Knowing who they are…
-
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Started this topic · Compounds › Oral incretins · 4 May 2025 · 42 likes The SOUL trial and oral semaglutide cardiovascular outcomes — setting out what I have, and where I think it stops being reliable. I have seen LEADER ( N Engl J Med ,…
-
Reading an MS report that only gives you a single number Replied, post #65 · Analytics › Mass spectrometry · 29 Apr 2025 · 22 likes Quantitation by MS: most quantitation is done by LC-UV detection at 214 nm, not by MS, because extinction coefficients are better known. MS can quantify if an internal…
-
Retatrutide dose escalation in the published trials Replied, post #155 · Compounds › Retatrutide · 19 Apr 2025 · 2 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Coming back to: Over-dilution: when your dose falls below one readable graduation Replied, post #5 · Practice › Reconstitution · 18 Apr 2025 · 20 likes Worth separating two things that the opening post runs together. How much of the diluent volume the powder itself displaces: for a small peptide vial, the powder volume…
-
Second pass at: Retatrutide mass and identity: what a report should show Replied, post #21 · Compounds › Retatrutide · 14 Apr 2025 · 14 likes TRIUMPH is phase 3 and it is ongoing. No phase 3 results exist. Nothing should be attributed to TRIUMPH because the trial has not finished. When it does, this page will…
-
Second pass at: Pen dose counters: what a click does and does not guarantee Replied, post #11 · Devices › Pens & autoinjectors · 3 Apr 2025 · 8 likes Injection duration: most pens deliver the dose over several seconds. Holding the button down for the full duration ensures complete delivery. Releasing early can result…
-
Counter-ion form: the field almost nobody reports — one year on Replied, post #11 · Analytics › COA interpretation · 19 Feb 2025 · 5 likes When a document puts the specification in the result column, it has told you the release criterion, not the measurement. Those are different claims and the second is…
-
Cost per milligram, computed honestly across formats — the long version Replied, post #10 · Access › Pricing · 15 Feb 2025 · 10 likes post #9 answers the question as asked. The question underneath it is different. Pharmacy acquisition cost: a pharmacy pays less than the patient pays, even at insurance…
-
[2026 update] Lipid changes during rapid weight loss: the expected trajectory Replied, post #44 · Clinical › Bloodwork · 4 Feb 2025 · 1 like post #43 is right about the mechanism and I think understates the practical bit. HbA1c and glucose: HbA1c reflects average glucose over months; a spot glucose…
-
Second pass at: Regression to the mean in progress reports Replied, post #34 · Research Methods › Statistics · 24 Jan 2025 · 0 likes Worth separating two things that post #30 runs together. Absence of evidence and evidence of absence: if a study is small and finds no effect, that is absence of…
-
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #3 · Clinical › Comorbidities · 24 Jan 2025 · 0 likes post #2 is right about the mechanism and I think understates the practical bit. Hepatic steatosis and MASH: a phase 2 trial in semaglutide for steatohepatitis showed…
-
Biased agonism: a real phenomenon, an over-used explanation — what changed since Replied, post #20 · Pharmacology › Receptor biology · 7 Jan 2025 · 10 likes GIP receptor signalling: the glucose-dependent insulinotropic peptide receptor (GIP) is involved in glucose-stimulated insulin secretion. GIP agonism is thought to…
-
Revisiting: What a well-designed human trial of a secretagogue would look like Replied, post #10 · Compounds › Secretagogues & GH axis · 31 Dec 2024 · 1 like Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #113 · Compounds › Tirzepatide · 27 Dec 2024 · 6 likes SURMOUNT-4 used a randomised withdrawal design: everyone titrated, then those on maintenance were randomised to continue or placebo. Continuation maintained effect;…
-
Triple agonism: additive, synergistic, or neither? Replied, post #4 · Compounds › Retatrutide · 16 Dec 2024 · 0 likes The phase 2 obesity paper reported dose-dependent weight reduction of a magnitude that attracted attention. It also reported dose-dependent heart-rate increases. The…
-
Promotion criteria, and the one that stops most nominations Replied, post #112 · Documentation › Doc review · 13 Nov 2024 · 15 likes Interdependencies: if updating one page requires updating related pages, posting that connection here helps the maintainers see the scope of work.
-
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #23 · Compounds › Repair & healing peptides · 9 Nov 2024 · 0 likes The distinction between "no evidence it works" and "evidence it does not work": we have the first for these compounds. That is genuinely different from the second and…
-
Irish differences from the UK position Replied, post #65 · Regional › UK & Ireland · 29 Oct 2024 · 0 likes Picking up post #62: that is the part I would want checked first. Importing for personal use: importing a prescription-only medicine without a prescription is not…
-
Research-use-only status: what it means legally and practically — a second dataset Started this topic · Compounds › Other compounds · 6 Oct 2024 · 26 likes Research-use-only status: what it means legally and practically — a second dataset — setting out what I have, and where I think it stops being reliable. Comparing FLOW…
-
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #83 · Clinical › Bloodwork · 5 Oct 2024 · 7 likes Coming back to post #81, because the follow-up matters more than the original answer. Biological variation: the person-to-person variation in a biomarker for a healthy…
-
Second pass at: Sodium, potassium and magnesium when intake drops Replied, post #128 · Nutrition & Training › Hydration & electrolytes · 2 Oct 2024 · 3 likes Potassium: similar to sodium; losing weight involves some potassium loss. Bananas, sweet potatoes, and other potassium-rich foods help. Severe depletion is rare but…
-
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #73 · Practice › Dosing & titration · 29 Sep 2024 · 27 likes post #72 answers the question as asked. The question underneath it is different. Reaching a dose and staying there for a year: the question of whether a stable dose…
-
SURPASS-2 and the comparator dose question that will not go away Replied, post #24 · Compounds › Tirzepatide · 29 Sep 2024 · 5 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Converting between mg/mL and units per dose, both directions Replied, post #33 · Practice › Reconstitution · 28 Sep 2024 · 0 likes Coming back to post #31, because the follow-up matters more than the original answer. Arithmetic step by step: a 5 mg vial with 2 mL of diluent gives (5 mg) / (2 mL) =…
-
Second pass at: Journal club: LEADER as the historical anchor Replied, post #21 · Evidence › Journal club · 12 Jul 2024 · 0 likes TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be attributed to it because it has not finished. When it does, this discussion will return to it.
-
Oral contraceptives and delayed emptying: what the data shows Replied, post #25 · Practice › Interactions · 10 Jul 2024 · 9 likes This follows post #22 rather than contradicting it. Thyroid medications: semaglutide is associated with a slowing of gastric emptying, which might affect thyroid…